Last edition
News about "Torrent pharma"
Torrent Pharma Approves USD 1.51 Billion Bond Fundraising Plan
Torrent Pharmaceuticals has approved a plan to raise up to USD 1.51 billion through the issuance of secured, rated, listed and redeemable non-convertible debentures (NCDs), according to a regulatory filing.
Torrent Pharma | 06/01/2026 | By Darshana
Torrent Pharma to Acquire Controlling Stake in JB Pharma from KKR in INR 25,689 Crore Deal
Torrent Pharmaceuticals has announced plans to acquire a controlling stake in JB Pharma from KKR in an INR 25,689 crore deal, paving the way for a merger that will significantly boost its Indian market position and global expansion strategy.
Torrent Pharma | 01/07/2025 | By Mrinmoy Dey | 323
Torrent Pharma joins race to acquire stake of Cipla promoters
Torrent Pharma joins race to acquire stake of Cipla promoters
Torrent Pharma | 24/08/2023 | By Sudeep Soparkar | 771
US FDA conducts Pre-Approval Inspection of oral oncology manufacturing facility in Gujarat
The company has been issued a Form 483 with 1 observation, which is procedural
Torrent Pharma | 20/03/2023 | By Sudeep Soparkar | 823
Torrent Pharma gets US FDA warning letter for Gujarat facility
The company said that this inspection classification will not have an impact on existing supplies or revenues from this facility
Torrent Pharma | 25/01/2023 | By Sudeep Soparkar | 1279
Aman Mehta added as a Director at Torrent Pharma
Aman Mehta is appointed as Director on the Board of Torrent Pharma from 1st August, 2022.
Torrent Pharma | 30/07/2022 | By Sudeep Soparkar | 889
Torrent Pharmaceuticals puts faith in local market, to focus on new drug launches
Torrent Pharmaceuticals is optimistic that the future of Indian drug makers is in the domestic market, as it looks at new launches in the lucrative chronic therapy areas
Torrent Pharma | 12/03/2020 | By Darshana | 607
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy